Global Livestock mRNA Vaccines Market Growth 2025-2031

The global Livestock mRNA Vaccines market size is predicted to grow from US$ 16.3 million in 2025 to US$ 29.7 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.

Livestock mRNA vaccines are a new type of vaccine developed to protect farm animals from infectious diseases using messenger RNA (mRNA) technology. These vaccines work by delivering genetic instructions that enable the animal's cells to produce a harmless portion of a pathogen, such as a viral protein, triggering an immune response without using live or inactivated pathogens. Compared to traditional vaccines, mRNA vaccines offer advantages such as faster development, adaptability to emerging diseases, and reduced reliance on cell cultures. They are being explored for use in preventing diseases like swine fever, and bovine respiratory diseases, improving both animal health and food security.

United States market for Livestock mRNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Livestock mRNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Livestock mRNA Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Livestock mRNA Vaccines players cover Ceva Animal Health, Merck Animal Health, Areterna, Bayer, BioNTech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Livestock mRNA Vaccines Industry Forecast” looks at past sales and reviews total world Livestock mRNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Livestock mRNA Vaccines sales for 2025 through 2031. With Livestock mRNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Livestock mRNA Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Livestock mRNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Livestock mRNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Livestock mRNA Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Livestock mRNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Livestock mRNA Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Livestock mRNA Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Injectable Drug Administration
Non-invasive Drug Administration

Segmentation by Application:
Cattle
Pigs
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Ceva Animal Health
Merck Animal Health
Areterna
Bayer
BioNTech
Genvax Technologies
BioVenic
Moderna
Ruipu Biotechnology
Jinyu Bio-technology
Shanghai Shen Lian Biomedical
Suzhou Kerui Meide Biomedical Technology
Shanghai Rnacure Biopharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Livestock mRNA Vaccines market?

What factors are driving Livestock mRNA Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Livestock mRNA Vaccines market opportunities vary by end market size?

How does Livestock mRNA Vaccines break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.